Ticker: BEAM

Company: Beam Therapeutics Inc.

Person: Christine Bellon, officer

Transaction date: Jan. 22, 2026

Reporting date: Jan. 26, 2026

Average share price: 34.0

Sold 1371.0 shares for 46614.0